Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equine Rabies Immunoglobulin on Day 7 after Vaccination
NCT03524417Unknown
- Sponsor
- Queen Saovabha Memorial Institute
- Start
- Apr 2018
- Primary completion
- Dec 2023
- Modality
- IG (Immune Globulin)
- Countries
- 1
01
Overview
Open-label trial of Equine Rabies Immunoglobulin in rabies, sponsored by Queen Saovabha Memorial Institute. Primary endpoint: Rabies neutralizing antibody titers at 365 days. Status: unknown.
02
Drugs
Equine Rabies Immunoglobulin
03
Conditions
rabies
Beyond the preview
Go deeper on NCT03524417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03524417.